Thus during the treatment of heart failure, these results are consistent with both ACE-inhibitor and ARB therapy decreasing Ang II mediated signaling to alter the vascular phenotype by preventing the fall in LZ+ MYPT1 expression. The gene discussed is ACE; the disease is heart failure.